Katsuhiro Hamada

Title: Katsuhiro Hamada: Innovator in Therapeutic Solutions

Introduction

Katsuhiro Hamada is a notable inventor based in Tochigi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing therapeutic agents for gastritis. His innovative approach has led to the creation of a unique pharmaceutical composition that addresses this common ailment.

Latest Patents

Hamada holds a patent for a therapeutic agent for gastritis. This patent describes a pharmaceutical composition containing 3,4,5-trimethoxy-N-3-piperidylbenzamide, commonly known as troxipide, as the active ingredient. The composition is designed to be administered orally in various forms, including tablets, capsules, granules, and fine granules. This innovation provides a new option for patients suffering from gastritis.

Career Highlights

Katsuhiro Hamada is associated with Kyorin Seiyaku Kabushiki Kaisha, a company known for its commitment to developing effective pharmaceutical solutions. His work at this organization has been instrumental in advancing therapeutic options for gastrointestinal disorders.

Collaborations

Hamada has collaborated with notable colleagues, including Kazunori Kasuga and Haruo Sekiguchi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.

Conclusion

Katsuhiro Hamada's contributions to the development of therapeutic agents for gastritis highlight his role as an important figure in the pharmaceutical industry. His innovative work continues to impact the lives of patients, providing them with effective treatment options.